The American laboratory Pfizer invoiced 25.7 billion dollars in the first quarter of 2022, an increase of 77% compared to the same period last year, largely thanks to the sales of its anticovid vaccine.
The firm also maintained the sales forecast for its Paxlovid anticovid pill of 22,000 million dollars in the year.
Meanwhile, Pfizer revised down its full-year profit estimate, mainly due to a change in accounting standards.
The city of Chitré and the rest of the communities in the province of Herrera will
Technicians from the Wildlife and Biodiversity Section of the Ministry of the Environment (MiAMBIENTE) in Panama
Professor Gloria Bennett, from the Faculty of Computer Systems Engineering of the Technological University of Panama
The National Police of Panama has organized an extensive security device in collaboration with emergency and
The WBSC (World Baseball & Softball Confederation) announced the Groups of the Premier Cup 12, leaving
Sending Data… 
